Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide for Prevention of COVID-19 Outbreaks
NCT04406246Phase 4Completed
- Sponsor
- Hospital Materno Perinatal Mónica Pretelini Sáenz
- Start
- May 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nitazoxanide in coronavirus disease 2019 (COVID-19), sponsored by Hospital Materno Perinatal Mónica Pretelini Sáenz. Started May 2020; status: completed.
02
Drugs
nitazoxanide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04406246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04406246.